EGF Receptor Signaling Modulates YAP Activation and Promotes Experimental Proliferative Vitreoretinopathy-Reference-Cited by-同舟云学术

EGF Receptor Signaling Modulates YAP Activation and Promotes Experimental Proliferative Vitreoretinopathy

Published:2022-07-27 Issue:8 Volume:63 Page:24
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Zhang Wei¹²,Li Jing¹

Affiliation:

1. Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Tianjin Eye Institute, Clinical College of Ophthalmology Tianjin Medical University, Tianjin, China

2. Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Reference47 articles.

1. Infographic: slow-release dexamethasone in proliferative vitreoretinopathy (PVR);Mostafa;Eye (Lond),2022

2. Proliferative vitreoretinopathy: a review;Idrees;Int Ophthalmol Clin,2019

3. New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies;Sang;Drug Deliv,2018

4. Phosphoinositide 3-kinase d inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells;Han;J Biol Chem,2019

5. Epidermal growth factor receptor exists in the early stage of proliferative vitreoretinopathy;Yan;Can J Ophthalmol,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin inhibition attenuates EGF-induced epithelial mesenchymal transformation of human RPE cells via the EGFR/MAPK pathway;PLOS ONE;2024-08-30

2. Inhibition of EGFR attenuates EGF-induced activation of retinal pigment epithelium cell via EGFR/AKT signaling pathway;International Journal of Ophthalmology;2024-06-18

3. YAP in development and disease: Navigating the regulatory landscape from retina to brain;Biomedicine & Pharmacotherapy;2024-06

4. The Hippo signalling pathway and its impact on eye diseases;Journal of Cellular and Molecular Medicine;2024-04

5. In vitro laboratory models of proliferative vitreoretinopathy;Survey of Ophthalmology;2023-09